PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
There is an FDA-approved cannabis-based treatment for epilepsy [PMID:35991815].
Clinical research is investigating the antipsychotic and neuroprotective properties of CBD [PMID:35991815].
CBD is associated with anticancer, antioxidant, anti-inflammatory, and anxiolytic effects [PMID:39654401].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32906622 (2020) — Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. · Molecules (Basel, Switzerland)
- 2.PMID: 38081533 (2024) — The comprehensive review about elements accumulation in industrial hemp (Cannabis sativa L.). · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
- 3.PMID: 34683621 (2021) — Bioactive Hemp Clothing Modified with Cannabidiol (CBD) Cannabis sativa L. Extract. · Materials (Basel, Switzerland)
- 4.PMID: 37761214 (2023) — The Role of Hemp (Cannabis sativa L.) as a Functional Food in Vegetarian Nutrition. · Foods (Basel, Switzerland)
- 5.PMID: 35991815